UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           Washington, D. C. 20549
                                 FORM 10-QSB


(x )   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the quarterly period ended        September  30, 2000
                                 ________________________________

(  )   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the transition period from _______________ to ____________________


Commission File number      000-26119
                        ___________________


                        ALTRIMEGA  HEALTH  CORPORATION
              _________________________________________________
              (Exact name of registrant as specified in charter)

      Nevada                                        87-0631750
(State or other jurisdiction of                   (I.R.S. Employer
incorporation or organization)                     Identification No.)

 3672  East  Cove  Point Drive,  Salt Lake City, Utah          84109
_______________________________________________________    ____________
(Address of principal executive offices)                    (Zip Code)


                                 801-278-8000
              __________________________________________________
              Registrant's telephone number, including area code


           _______________________________________________________
            (Former name, former address, and former fiscal year,
                        if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports),  Yes [x] No [ ] and (2) has
been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

                    APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date

           Class               Outstanding as of September 30, 2000
     ____________________      _____________________________________
    Common  Stock, $0.001                    5,505,000

<PAGE>


                                    INDEX

                                                                       Page
                                                                       Number
PART I.

  ITEM 1. Financial Statements (unaudited)................................3

          Balance Sheets..................................................4
            September 30, 2000 and December 31, 1999

          Statements of Operations........................................5
            For the three and nine months ended September 30, 2000
            and 1999 and the period September 8, 1998 to
            September 30, 2000

          Statements of Cash Flows........................................6
             For the nine months ended September 30, 2000 and 1999
             and the period September 8, 1998  to September 30, 2000

          Notes to Financial Statements...................................7

  ITEM 2.  Plan of Operations.............................................9

PART II.   Signatures.....................................................9

<PAGE>


                        PART I - FINANCIAL INFORMATION

                         ITEM 1. FINANCIAL STATEMENTS


The accompanying balance sheets of Altrimega Health Corporation  ( development
stage company)  at September  30, 2000 and December 31 1999, and the related
statements of operations for the three and nine months ended September 30,
2000 and 1999 and the period September 8, 1998  to September 30, 2000,  the
statement of cash flows  for the nine months ended September  30, 2000 and
1999, and the period September 8, 1998 to September 30, 2000, have been
prepared by the Company's management and they do not include all information
and notes to the financial statements necessary for a complete presentation of
the financial position, results of operations, cash flows, and stockholders'
equity in conformity with generally accepted accounting principles.  In the
opinion of management, all adjustments considered necessary for a fair
presentation of the results of operations and financial position have been
included and all such adjustments are of a normal recurring nature.

Operating  results for the quarter ended September  30, 2000, are not
necessarily indicative of the results that can be expected for the year ending
December 31, 2000.

<PAGE>

                        ALTRIMEGA  HEALTH  CORPORATION
                         (Development Stage Company)
                                BALANCE SHEETS
                  September 30, 2000, and December 31, 1999
==============================================================================


                                                       Sept 30,    Dec 31,
                                                        2000         1999
                                                    ------------- ------------
ASSETS
CURRENT ASSETS

  Cash                                              $      1,052  $     4,125
                                                    ------------- ------------
   Total Current Assets                                    1,052        4,125
                                                    ------------- ------------
PROPERTY AND EQUIPMENT - Net of
   accumulated depreciation - Note 2                       2,326        2,626
                                                    ------------- ------------

ADVANCE DEPOSIT - LEASE - Note 3                               -        6,666
                                                    ------------- ------------
                                                    $      3,378  $    13,417
                                                    ============= ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES

  Note payable - related party - Note 4             $      5,000  $     5,000
  Accounts payable                                             -        1,500
                                                    ------------- ------------

   Total Current Liabilities                               5,000        6,500
                                                    ------------- ------------
STOCKHOLDERS' EQUITY

  Preferred stock
     10,000,000 shares authorized at $0.001
     par value; none outstanding                               -            -
  Common stock
     50,000,000 shares authorized at $0.001
     par value; 5,505,000 shares issued and
     outstanding on September 30; 5,000,000
     on December 31                                        5,505        5,000
  Capital in excess of par value                          91,495       41,500
  Deficit accumulated during the development
     stage                                               (98,622)     (39,583)
                                                    ------------- ------------

   Total Stockholders' Equity (deficiency)                (1,622)       6,917
                                                    ------------- ------------

                                                    $      3,378  $    13,417
                                                    ============= ============



  The accompanying notes are an integral part of these financial statements.

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENTS OF OPERATIONS
      For the Three and Nine Months Ended September 30, 2000,  and 1999
  and the Period September 8, 1998 (Date of Inception) to September 30, 2000

==============================================================================
<TABLE>
<CAPTION>

                          Three Months          Nine Months
                  -------------------------- -------------------------
                      Sept 30,   Sept 30,       Sept 30,   Sept 30,    Sept 8, 1998 to
                       2000       1999           2000       1999       Sept 30, 2000
                  ------------- ------------ ------------- ----------- -------------
<S>               <C>           <C>          <C>           <C>         <C>
REVENUES          $      3,388  $         -  $      9,703  $        -  $      9,703

EXPENSES                 3,610        3,135        68,742       3,135       108,325
                  ------------- ------------ ------------- ----------- -------------

NET LOSS          $       (222) $    (3,135) $    (59,039) $   (3,135) $    (98,622)
                  ============= ============ ============= =========== =============
NET LOSS PER
 COMMON SHARE

  Basic           $          -  $         -  $      (0.01) $        -
                  ------------- ------------ ------------- -----------
AVERAGE
 OUTSTANDING
  SHARES

   Basic             5,355,000    4,500.000     5,355,000   4,500,000
                  ============= ============ ============= ===========






The accompanying notes are an integral part of these financial statements.

</TABLE>
<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENT OF CASH FLOWS
            For the Nine Months Ended September 30, 2000, and 1999
  and the Period September 8, 1998 (Date of Inception) to September 30, 2000

==============================================================================


                                                                Sept 8, 1998
                                        Sept 30,     Sept 30,   to Sept 30,
                                         2000         1999      2000
                                     ------------- ------------ -------------
CASH FLOWS FROM OPERATING ACTIVITIES

  Net loss                           $    (59,039) $    (3,135) $    (98,622)

    Adjustments to reconcile net
    loss to net cash provided by
    operating activities

      Depreciation and amortization         6,966            -        10,474
      Changes in accounts payable          (1,500)       1,083             -
                                     ------------- ------------ -------------

     Net Cash Used in Operations          (53,573)      (2,052)      (88,148)
                                     ------------- ------------ -------------
CASH FLOWS FROM INVESTING ACTIVITIES

    Purchase of equipment                       -       (1,800)       (2,800)
    Advance deposit - lease                     -      (10,000)      (10,000)
                                     ------------- ------------ -------------
                                                -      (11,800)      (12,800)
                                     ------------- ------------ -------------
CASH FLOWS FROM FINANCING ACTIVITIES

    Proceeds from loan                          -       20,000         5,000
    Proceeds from issuance of
     common stock                          50,500        4,100        97,000
                                     ------------- ------------ -------------
                                           50,500       24,100       102,000
                                     ------------- ------------ -------------
Net Increase (Decrease) in Cash            (3,073)      10,248         1,052

Cash at Beginning of Period                 4,125            -             -
                                     ------------- ------------ -------------

Cash at End of Period                $      1,052  $    10,248  $      1,052
                                     ============= ============ =============


The accompanying notes are an integral part of these financial statements.

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                        NOTES TO FINANCIAL STATEMENTS

=============================================================================

1.    ORGANIZATION

The Company was incorporated under the laws of the State of Nevada on
September 8, 1998 with the name of Mega International Health Corporation with
authorized common stock of 50,000,000 shares with a par value of $0.001 and
preferred stock of 10,000,000 shares with a par value of $0.001. The board of
directors will determine the powers and rights of the preferred stock when it
is issued. On June 23, 1999 the name was changed to Altrimega Health
Corporation.

The Company was organized for the purpose of marketing nutritional products.

The Company is in the development stage.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Methods
------------------

The Company recognizes income and expenses based on the accrual method of
accounting.

Dividend Policy
---------------

The Company has not  adopted a policy regarding payment of dividends.

Property and Equipment
---------------------

The equipment consists of office furniture and equipment which is being
depreciated over 5 and 7 years.

Income Taxes
------------

On June 30, 2000 the Company  had   a  net operating loss carryforward   of
$98,622. The  tax benefit from the loss carry forward  has been fully offset
by a valuation reserve because the use of the future tax benefit is doubtful,
since the Company has no operations on which to project  future  net profits.

The loss carryover will expire in 2022.

Basic and Diluted Net Income (Loss) Per Share
---------------------------------------------

Basic net income (loss) per share amounts are computed based on the weighted
average number of shares actually outstanding. Diluted net income (loss) per
share amounts are computed using the weighted average number of common shares
and common equivalent shares outstanding as if shares had been issued on the
exercise of the preferred share rights unless the  exercise becomes
antidilutive and then only the basic per share amounts are shown in the
report.


<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

==============================================================================


2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Comprehensive Income
--------------------

The Company adopted Statement of Financial Accounting Standards No. 130. The
adoption of this standard had no impact on the total stockholder's equity.

Recent Accounting Pronouncements
--------------------------------

The Company does not expect that the adoption of other recent accounting
pronouncements will have a material impact on its  financial statements.

Estimates and Assumptions
--------------------------

Management uses estimates and assumptions in preparing financial statements in
accordance with generally accepted accounting principles.  Those estimates and
assumptions affect the reported amounts of the assets and liabilities, the
disclosure of contingent assets and liabilities, and the reported revenues and
expenses.  Actual results could vary from the estimates that were assumed in
preparing these financial statements.

Financial Instruments
---------------------

The carrying amounts of financial instruments, including cash, advance
deposits, property and equipment and accounts payable,  are considered by
management to be their estimated fair values.

3. ADVANCE DEPOSIT - LEASE

The Company paid an advance deposit on the lease of office  and storage space.
The terms of the lease is $833 per month for twelve months.

4.  NOTE PAYABLE

The note payable consists of  a  no interest, demand loan, of $5,000 received
from a related party.

5.  RELATED PARTY TRANSACTIONS

70% of the outstanding common stock  was issued to a related parties.

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

=============================================================================

6.  GOING CONCERN

The company will need additional working capital for its  planned activity and
continuation of the Company  as a going concern is dependent upon obtaining
sufficient  working capital to be successful in  that effort and the
management of the Company has developed a strategy, which it believes will
accomplish this objective through additional equity funding, and long term
financing, which will enable the Company to operate for the coming year.

<PAGE>



                          ITEM 2. PLAN OF OPERATIONS


The Company was organized for the purpose of marketing nutritional products
and has completed the development of  its initial product line, and has
established relationships with suppliers of  the various nutrients comprising
the ALTRIMEGA Health products.  The Company has established a relationship
with a Utah nutritional manufacturer, which will provide the Company with
packaging, warehousing and distribution services.  The Company's products were
created as a result of the belief by management that a substantial "niche"
market exists in the nutritional supplement industry, for unique and effective
products.  Management believes its natural medicines and nutritional
supplements offer a better alternative to traditional nutritional supplements
currently being produced by providing specialized combinations of nutrients.

Products
--------

The Company has initially created natural medications and nutritional
supplements in the following categories:

1.  Weight-loss and fat management.
2.  Cardiovascular conditions.
3.  Antioxidant protection.
4.  Memory enhancement and senility prevention.
5.  Prostate protection and BHP reversal.
6.  Impotency reversal and sexual enhancement.
7.  Detoxification procedures.
8.  Daily nutritional requirements.

Additional products and programs, covering a variety of health needs, are in
development, and will be introduced into the market as the Company's financial
situation and operating and marketing results dictate.

Working Capital Needs
---------------------

The Company does not have the working capital to be successful in its plans
outlined above.

Continuation of the Company as a going concern is dependent upon obtaining the
working capital to  provide working capital for its planned activity. The
management of the Company has developed a strategy, which they believe can
obtain the needed working capital through additional equity funding and long
term debt which will enable the Company to be successful in its planned
efforts.

Liquidity and Capital Resources
-------------------------------

The Company will need additional working capital to  to finance its planned
activity.

Results of Operations
---------------------

The Company has  not started operations during this reporting period.

<PAGE>

                             PART 2 - SIGNATURES




                                  SIGNATURES



      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned there unto duly authorized.


                                        ALTRIMEGA HEALTH CORPORATION
                                        [Registrant]




Dated 10-30, 2000                 By /s/ Howard Abrams
                                     ------------------------
                                         Howard Abrams, President